Pay close attention to false positivity in the determinations of anti-HCV and anti-TP antibodies

doi:10.3969/j.issn.1673-8640.2015.12.001

Abstract

Abstract:

The false positivity in the determinations of anti-hepatitis C virus (HCV) antibody and anti-treponema pallidum (TP) antibody and the correspondence measures for solving this problem are presented. It is emphasized that the determinations of anti-HCV and anti-TP antibodies should use an antibody screening assay and a specific supplementary confirmation assay for the results showing repeatedly positive reaction in screening assay. Immunology test technicians in clinic and blood collection agencies should pay close attention to false positivity in the determinations of anti-HCV and anti-TP antibodies, which also is the purpose of this article.

Key words: Anti-hepatitis C virus antibody, Anti-treponema pallidum antibody, Screening assay, False positivity, Supplementary confirmation assay

CLC Number:

R446.61

ZHU Qinghui.. Pay close attention to false positivity in the determinations of anti-HCV and anti-TP antibodies[J]. Laboratory Medicine, 2015, 30(12): 1163-1166.

References 14

[1]	TIWARI AK, PANDEY PK, NEGI A, et al.Establishing a sample-to cut-off ratio for lab-diagnosis of hepatitis C virus in Indian context[J]. Asian J Transfus Sci, 2015, 9(2):185-188.
[2]	SINDERMANN JR, HOLTHAUS AJ, SCHEPERS M, et al.False-positive hepatitis C testing in long-term LVAD support[J]. ASAIO J, 2015, 61(3):e19.
[3]	ALTER MJ, KUHNERT WL, FINELLI L, et al.Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention[J].MMWR Recomm Rep,2003, 52(RR-3):1-13.
[4]	任芙蓉,龚晓燕,李京京,等. 献血员丙型肝炎病毒抗体酶免疫法检测试剂的测量值与其真阳性的相关性[J]. 中华肝脏病杂志,2005,13(4):255-258.
[5]	张瑞,李金明.丙型肝炎病毒感染临床检测程序的建立及结果报告与解释[J].中华检验医学杂志,2010,33(10):990-992.
[6]	郑金来,魏红山. HCV抗体实验室检测和结果报告指南[EB/OL]. (2012-12-13)[2015-09-11]. .
[7]	中国疾病预防控制中心.丙型肝炎病毒实验室检测技术规范[EB/OL]. (2012-02-16)[2015-09-17]. .
[8]	Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002[J]. MMWR Recomm Rep, 2002, 51(RR-6):1-78.
[9]	王露楠,邓巍,李金明. 梅毒螺旋体感染不同血清学诊断方法的临床评价[J].中华检验医学杂志,2002, 25(6):352-353.
[10]	方伟祯,谢文锋,丁睿,等. 300例住院患者梅毒血清学试验阳性结果分析[J]. 中国实用医药,2011,6(3):9-11.
[11]	WANG LN, LI JM.Evaluation of immunoglobulin M and G Western blot and ELISA for screening antibodies to Treponema pallidum in blood donors[J]. Sex Transm Dis, 2009, 36(7):413-416.
[12]	朱鸿,赵乙洁. 化学发光法检测特异性梅毒抗体的S/CO值的实验室评价[J]. 大连医科大学学报, 2013,35(3):298-299.
[13]	李金明. 感染性疾病血清学检验中应重视对弱反应性标本的确认[J]. 中华检验医学杂志,2006,29(7):577-580.
[14]	李金明.梅毒螺旋体感染临床检测程序的建立、结果报告和解释[EB/OL]. (2015-07-08)[2015-09-19]. .